Trial No.: ABBVIE M15-656
A Randomized, Double-Blind, Placebo Controlled Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in Treatment Naïve Subjects with Acute Myeloid Leukemia Who are Ineligible for Standard Induction Therapy
*Special Note – Patients Must be Able to Receive Treatment at Lutheran Hospital
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.